Lexeo Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $4.85 |
Previous Close | $4.75 |
Day Range | $4.80-$5.26 |
52W Range | $3.60-$10.99 |
Market Cap | $365.1M |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$62.3M |
Diluted EPS | -$1.12 |
News
See moreYahoo Finance • 3 days ago
Pre-Market Movers: BYAH, LXEO, ELTX Swing Big
Yahoo Finance • 3 months ago
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Yahoo Finance • 4 months ago
H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)’s PKP2 Program
Yahoo Finance • 6 months ago
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
About
CEO | Mr. R. Nolan Townsend M.B.A. |
CFO | Mr. Louis Tamayo |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |